drugset / Trial / NCT04188587
177Lu-PSMA-I＆T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and efficacy of 177 Lu -labeled PSMA ligand(PSMA-I＆T) in the treatment of mCRPC in Asianethics.
Timeline
- Start
- 2019-01-01
- Primary completion
- 2020-08
- Completion
- 2020-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 177Lu-PSMA-I&T | Other / unclassified | 2000 mbq | Intravenous |
| Subject | 177Lu-PSMA-I&T | Other / unclassified | 8000 mbq | Intravenous |